Stem Cell Therapy for Arthritis: What Patients Should Know

Medical illustration of an inflamed joint and stem cells, representing research into stem cell therapy for arthritis and joint-related conditions

Stem cell therapy for arthritis is an area of regenerative medicine being researched for certain joint-related conditions. Arthritis is a common condition that causes joint pain, stiffness, and reduced mobility, affecting millions of people worldwide. For individuals who have not found adequate relief from conventional treatments, this has become an area of regenerative medicine being researched for certain arthritic conditions.

For a broader national overview, patients may also review our page on stem cell therapy in Mexico, which outlines regulatory context, safety considerations, and general evaluation processes.

What Is Arthritis?

Arthritis is an umbrella term describing inflammation or degeneration of one or more joints. It can affect people of all ages and commonly leads to pain, stiffness, swelling, and reduced function.

Common forms of arthritis include:

How Stem Cell Therapy for Arthritis Is Being Studied

Investigational therapy using stem cells is being researched for its potential role in supporting biological processes related to joint environments affected by inflammation or degeneration.

Researchers are studying how stem cells may:

Types of Arthritis Patients Commonly Ask About

Stem Cell Therapy for Arthritis and Joint-Related Conditions

Some patients explore regenerative medicine approaches for arthritis after conservative treatments fail in the context of:

  • Osteoarthritis
    A degenerative joint condition commonly affecting the knees, hips, shoulders, and spine, and frequently associated with chronic joint pain and stiffness.

    In this context, some patients also explore investigational options for conditions involving the knees, hips, shoulders, or chronic back pain.

  • Rheumatoid and Inflammatory Arthritis
    Autoimmune forms of arthritis involve systemic inflammation and may require specialized medical management. Stem cell therapy for inflammatory arthritis remains under investigation and may not be appropriate for all patients.

    A thorough medical review is essential.

  • Post-Traumatic Arthritis
    Joint degeneration that develops after injury may present differently from age-related arthritis. Some patients explore regenerative options when conservative treatments are insufficient.

Who May Be Considered for Evaluation?

A patient may be considered for evaluation if they:

Risks, Limitations, and Important Considerations

Outcomes from stem cell–based treatments for arthritis vary between patients, potential risks and limitations, including:

Patients should understand that:

Why Some Patients Explore Stem Cell Therapy in Mexico

Some U.S. patients explore arthritis treatment options outside the United States due to:

Rejuvacell Medical Group provides care to international patients with a focus on:

Medical Oversight and Patient Care

All procedures at Rejuvacell Medical Group are:

Frequently Asked Questions

Stem cell therapy is not FDA-approved for arthritis. Many procedures remain investigational.

Some patients explore regenerative options before surgery, but surgery may still be necessary depending on severity.

Responses vary based on arthritis type, joint affected, and individual health factors.

Request an Arthritis Consultation

If you are living with arthritis and want to learn more about investigational stem cell therapy options, you may request a confidential consultation.

Scroll to Top